# Meloxicam in Mohs Micrographic Surgery

> **NCT07200544** · PHASE4 · RECRUITING · sponsor: **University of Oklahoma** · enrollment: 300 (estimated)

## Conditions studied

- Postoperative Pain, Acute
- Skin Cancer

## Interventions

- **DRUG:** Meloxicam 7.5 mg
- **DRUG:** Meloxicam 15 mg
- **DRUG:** Acetaminophen 500mg

## Key facts

- **NCT ID:** NCT07200544
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-15
- **Primary completion:** 2026-06-02
- **Final completion:** 2026-08-02
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07200544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07200544, "Meloxicam in Mohs Micrographic Surgery". Retrieved via AI Analytics 2026-05-19 from https://api.ai-analytics.org/clinical/NCT07200544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*